Supplementary Figure S1 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer
Authors:
- Maria M. RubinsteinMRMaria M. Rubinstein
- Jennifer Y. GeJGJennifer Y. Ge
- Qin ZhouQZQin Zhou
- Alexia IasonosAIAlexia Iasonos
- Britta WeigeltBWBritta Weigelt
- Pier SelenicaPSPier Selenica
- Daniel M. MuldoonDMDaniel M. Muldoon
- Chaitanya BandlamudiCBChaitanya Bandlamudi
- Caitlin KaczynskiCKCaitlin Kaczynski
- Viktoriya ParoderVPViktoriya Paroder
- Kelsey HigginsKHKelsey Higgins
- Pooja ShahPSPooja Shah
Open Access
- 15 June 2026
- other
- Published by American Association for Cancer Research (AACR)